Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Non-Trachomatis Chlamydiaceae Species Cause Trachoma
Link ID 2715
Title Non-Trachomatis Chlamydiaceae Species Cause Trachoma
Url http://www.medscape.com/viewarticle/569262?src=rss
Description Trachoma, a leading cause of preventable blindness in the world, may be caused by Chlamydiaceae species other than Chlamydia trachomatis, according to a report in the January PLoS Medicine. Reuters Health Information
Category Articles > Hematology-Oncology
Keywords
Date Jan 26, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. EGFR Gene Variants Have Gender-Specific Effects on Colon Cancer Survival
  Functional polymorphisms in the gene expressing epidermal growth factor receptor (EGFR) have opposite prognostic implications for male and female patients with metastatic colon cancer, new study findings indicate. Reuters Health Information
Category:   Articles > Hematology-Oncology


2. A Case of Synchronous Bilateral Testicular Seminoma
  Bilateral synchronous testicular tumors are rare but may require different management from what is routine for unilateral tumors. The current case report features a literature review that examines the best practice for the management of bilateral testicular tumors. Nature Clinical Practice Urology
Category:   Articles > Hematology-Oncology


3. Therapy Insight: Anthracyclines and Trastuzumab - The Optimal Management of Cardiotoxic Side Effects
  Trastuzumab may significantly improve survival among women with advanced breast cancer, but there are concerns about cardiotoxicity associated with this targeted therapy. The current analysis examines this issue and means to prevent cardiac events among women receiving trastuzumab. Nature Clinical Practice Oncology
Category:   Articles > Hematology-Oncology


4. Everolimus Prolongs Progression-Free Survival in Metastatic Renal Cancer
  Everolimus, an investigational mTor inhibitor, improved survival in patients with metastatic renal cell carcinoma whose disease had progressed after treatment with sunitinib and/or sorafenib. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. New Agents in Thyroid Cancer Trials Suggest Treatment Paradigm Shift is "Not Far Off"
  Several new agents are showing activity in refractory thyroid cancer, suggesting that a treatment paradigm shift is "not far off." Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS